Loading the section
The price of 10x Genomics, Inc. (TXG) on October 9, 2026 is 80.65 USD, +4.36% on the day. Over 52 weeks the stock traded between 11.16 USD and 102.81 USD; the price now sits 76% of the way up that range. Over the past year the price changed by +568.19%. Market capitalization is 9.50 billion USD, rank 8 among 21 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
10x Genomics, Inc. trades on Nasdaq under the ticker TXG. The company belongs to the Health care sector. The trading history on this page starts on 12 September 2019.
Over the past 52 weeks TXG has traded between 11.16 $ and 102.81 $. As of 09 October 2026 the price stood 75.82 % of the way from the 52-week low to the high.
Over one year TXG shares rose 568.19 %; over six months they rose 246.58 %. Volatility over 90 days is 80.18 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 14.9, above the sector median of 3.9. Price to book is 11.7, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 79.16 | 85.12 | 79.16 | 80.65 | 4M |
| 08 October 2026 | 73.50 | 77.58 | 70.94 | 77.28 | 6M |
| 07 October 2026 | 77.52 | 82.72 | 73.00 | 76.10 | 9M |
| 06 October 2026 | 100.33 | 102.81 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
10x Genomics, Inc. (TXG) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 642.8m $, net income was -43.5m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588, US
10x Genomics, Inc. reported revenue of 639M $ and a net loss of 23M $ over the last four quarters. Net margin is −3.55 %. Revenue changed by +2.26 % year over year. Earnings per share are −0.17 $. Market capitalisation is 9.5B $.
TXG has a return on equity of −2.78 %, above the sector median of −41.68 %. Return on assets is −2.23 %, above the sector median of −32.11 %. Operating margin is −6.06 %, above the sector median of −26.84 %.
| 303M |
| MTDMettler-Toledo International, Inc. | 1,550 | +1.34 % | 295M |
| BRKRBruker Corporation | 59.00 | +1.86 % | 137M |
| AVTRAvantor, Inc. | 15.67 | +1.82 % | 130M |
| BIOBio-Rad Laboratories, Inc. | 366.16 | +1.60 % | 98M |
| 79.90 |
| 80.66 |
| 9M |
| 05 October 2026 | 93.50 | 98.32 | 92.26 | 97.74 | 3M |
| 02 October 2026 | 90.04 | 94.56 | 88.14 | 93.50 | 3M |
| 01 October 2026 | 89.30 | 92.92 | 86.75 | 88.76 | 3M |
| 30 September 2026 | 92.30 | 95.16 | 90.23 | 90.36 | 4M |
| 29 September 2026 | 89.24 | 91.99 | 87.29 | 90.04 | 3M |
| 28 September 2026 | 86.00 | 89.95 | 84.27 | 88.50 | 3M |
| 25 September 2026 | 83.76 | 86.16 | 80.72 | 85.71 | 3M |
| 24 September 2026 | 75.50 | 85.93 | 74.60 | 84.11 | 4M |
| 23 September 2026 | 80.37 | 81.93 | 74.75 | 75.62 | 3M |
| 22 September 2026 | 79.42 | 82.68 | 77.50 | 80.70 | 4M |
| 21 September 2026 | 79.15 | 80.11 | 76.73 | 79.10 | 2M |
| 18 September 2026 | 77.64 | 78.08 | 75.21 | 76.60 | 3M |
| 17 September 2026 | 75.38 | 79.94 | 75.00 | 76.97 | 3M |
| 16 September 2026 | 74.50 | 77.87 | 71.44 | 72.68 | 4M |
| 15 September 2026 | 70.13 | 75.61 | 70.11 | 74.39 | 3M |
| 14 September 2026 | 67.04 | 70.46 | 64.73 | 70.11 | 3M |